4//SEC Filing
Webb Carol 4
Accession 0001213900-24-069244
CIK 0001851484other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:24 PM ET
Size
11.9 KB
Accession
0001213900-24-069244
Insider Transaction Report
Form 4
Webb Carol
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+150,000→ 150,000 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001671111
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:24 PM ET
- Size
- 11.9 KB